Yosra M Aljawai

20PUBLICATIONS
51CO-AUTHORS
Haematological tumoursHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 31, 2026
Phase I/II Trial of Evomela for Autologous Transplant in Myeloma: Schedule Optimization and Matched Comparison with MEL200.

|Jul 28, 2026
The Pitfalls of Categorizing Donor Age: Arbitrary Cutoffs Fail to Predict Survival in Haploidentical HCT.

|Jul 24, 2026
Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.

|Jul 06, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

|Jun 17, 2026
Donor-specific HLA mismatch: haploidentical versus 7/8 mismatched unrelated donor hematopoietic cell transplantation with PTCy.

|Jun 05, 2026
D-VRD induction and autologous transplant in patients ≥70 years.

Pageof 4

Frequent Collaborators

9 joint publications

Jeremy Ramdial

9 joint publications

Yago Nieto

9 joint publications

Rohtesh S Mehta

8 joint publications

Richard E Champlin